Aptevo Therapeutics: Funding, Investors & Team (Sep 2026)
Aptevo Therapeutics is a biotech company based in Seattle that focuses on developing new treatments for cancer and blood disorders. They use a special technology called ADAPTIR™ to improve outcomes for cancer patients. The company is known for its supportive work environment, culture of innovation, and unique platform technology. As a result, Aptevo has been able to attract talented individuals with experience in other leading biotech companies such as Trubion, ZymoGenetics, Immunex, Dendreon, and VLST.
Aptevo Therapeutics has raised $90.3M across 9 funding rounds on record, the most recent an undisclosed round of $1.5M announced in Jun 2026.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Aptevo Therapeutics Company Profile and Key Stats
Latest funding round on record: Jun 2026.
Aptevo Therapeutics Funding Rounds
1 of 9 rounds was announced without a disclosed amount and is excluded from the total.
Aptevo Therapeutics raised $4.6M in an undisclosed round announced in Apr 2024.
5 months later, an undisclosed round of $3.0M was announced in Sep 2024.
3 months later, an undisclosed round of $6.2M was announced in Dec 2024.
4 months later, an undisclosed round of $2.0M was announced in Apr 2025.
2 months later, an undisclosed round of $8.0M was announced in Jun 2025.
7 months later, an undisclosed round of $60.0M was announced in Jan 2026.
4 months later, an undisclosed round was announced in May 2026 with no disclosed amount.
1 month later, an undisclosed round of $1.5M was announced in Jun 2026.
Aptevo Therapeutics Founders and Leadership Team
Contact details for the Aptevo Therapeutics team: 1 has a LinkedIn profile.
Start 14-day free trial →Aptevo Therapeutics Funding Compared to Other Biotechnology Startups
Aptevo Therapeutics' latest round of $1.5M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Aptevo Therapeutics in Biotechnology and Seattle
Companies Similar to Aptevo Therapeutics
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Aptevo Therapeutics Funding FAQs
What does Aptevo Therapeutics do?
Aptevo Therapeutics is a biotech company based in Seattle that focuses on developing new treatments for cancer and blood disorders. They use a special technology called ADAPTIR™ to improve outcomes for cancer patients. The company is known for its supportive work environment, culture of innovation, and unique platform technology. As a result, Aptevo has been able to attract talented individuals with experience in other leading biotech companies such as Trubion, ZymoGenetics, Immunex, Dendreon, and VLST.
How much funding has Aptevo Therapeutics raised?
Aptevo Therapeutics has raised $90.3M across 9 rounds on record. The most recent is an undisclosed round of $1.5M announced in Jun 2026.
When did Aptevo Therapeutics last raise funding?
Aptevo Therapeutics' most recent funding round on record is an undisclosed round of $1.5M, announced in Jun 2026.
Who founded Aptevo Therapeutics?
FundedIQ lists Marvin L White (Founder), Marvin White (Founder) at Aptevo Therapeutics.
Where is Aptevo Therapeutics headquartered?
Aptevo Therapeutics is based in Seattle, Washington, United States.
How many employees does Aptevo Therapeutics have?
Aptevo Therapeutics is in the 51-100 employee band.
How does Aptevo Therapeutics' funding compare to other Biotechnology startups?
Aptevo Therapeutics' latest round of $1.5M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Aptevo Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Aptevo Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.